A Dose Ranging Study Evaluating Efficacy and Safety of NI-03

Clinical trial NCT02693093 · COMPLETED

Trial details

NCT number: NCT02693093
Sponsor: Kangen Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Pancreatitis

Start date: 2016-02-24
Primary completion: 2021-09-30
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.